Layer 1

NPA appoints credit unions chief Mark Lyonette as new CEO

Mark Lyonette: It's an honour to serve thousands of independent community pharmacies
Mark Lyonette: It's an honour to serve thousands of independent community pharmacies

The National Pharmacy Association (NPA) has announced its new chief executive, Mark Lyonette, will join the representative body in June.

Mr Lyonette is currently chief executive of the Association of British Credit Unions. He has worked for the organisation – a “leading voice on issues such as financial inclusion, and banking and payments reform” – for 20 years.

During his tenure, the association's membership quadrupled and its assets grew by almost 900%, according to its website.
NPA chairman Ian Strachan said Mr Lyonette “brings with him a great deal of experience of running trade associations, membership bodies, and leading a complex, regulated sector through change”.
Mr Lyonette’s role will see him “further develop the capabilities and performance of the NPA in order to help transform the prospects of the pharmacy sector”, Mr Strachan said, adding: “We look forward eagerly to his arrival.”
Mr Lyonette said: “I am delighted to be joining the NPA later this year. It is an honour to have the opportunity to serve the thousands of independent community pharmacies who rely on the NPA to provide essential services, a strong voice and a vehicle for collective progress.

“I am looking forward to working with the board and the executive team to strengthen the NPA, and develop this vital service for its members.”

Mr Lyonette will be the first NPA chief executive since Mike Holden left the role in 2014, and follows David Simons, who was interim chief operating officer, who left in July 2017.

What issues would you like to see the new NPA CEO champion?

Mohammed Patel, Community pharmacist

I don't agree. The C+D do a good job of removing and moderating offensive comments. Better that the C+D remove or redact the comment rather than someone being charged with libel.

And yes, you can read on here the exact reasons why GPhC do not go after the multiples.

Some people suggest that they are in cahoots, which would seem to be obvious, and some would suggest they they are scared of the high profile lawyers so continue biting the hand that feeds them by going after individual pharmacists who are seen as easy pickings.

I think it it is high time that the UK government took a very close look at the finnaces of certain organisations to see if and when any kind of kickbacks are taking place. The GPhC will never attack the multiples, but will gladly go after a pharmacist who has worked 30 years, but who has been involved in a dispensing incident which is alleged to have caused harm, though almost certainly did not.

Most dispensing incidents do not cause harm. The backscratching underhanded relationships between organisations who are supposed to be looking after patients, and not themselves, almost certainly causes the most harm to everybody.

Corporate greed, a peculiar attitude to "regulation", and the self-serving attitude of using the most expensive office space in the UK should get everybody thinking about what is really going on in their industry.

Google, Microsoft and eBay, yes I understand. By why are the GPhC, who WE ARE PAYING FOR, using such outrageously expensive offices? Move to Slough, High Wycombe or Milton Keynes and stop wasting pharmacists' registration fees!

PS: It might also be a good time to stop making excuses and tackle the way in which muliples are running their pharmacies, and how they are treating their pharmacists (who are paying your wages).

Graham Pharmacist, Community pharmacist

Looks like he had a few last night.

Mohammed Patel, Community pharmacist

How many people think that it's ok to turn up to work looking like you drank 12 pints last night?

Brian Austen, Senior Management

He cannot have a good understanding of the NHS and Community Pharmacy. Maybe the NPA are going to use his financial and credit union skills to set up credit facilities for its struggling members!

Mohammed Patel, Community pharmacist

Well, it's all about finances, as I suspect you already understand. Prepare for the heads of our profession to be previous kebab-shop owners, Dominos pizza franchisees, and Primark executives.

Mohammed Patel, Community pharmacist

Well, if he thinks he can improve the NPA's assets by 900%, I think he might be a bit disappointed. Anyway, it's another non-pharmacist. Who is next? Lidl? Poundstretchers? Matalan? Greggs?

Anyone who can get blood out of a stone.

Surely when we start getting people from Dixons, Wimpy, Oxfam and McDonalds, we know it's time to either throw in the towel or have a late night meeting with your local suspension bridge.

Graham Pharmacist, Community pharmacist

That may be a bit extreme, Mr. Patel, but I understand where you are coming from. English pharmacists pay out a very large amount of money to the regulator, in the hope that they will actually regulate (god forbid) and so they can work their job. But what can we do when they fail? I suspect that the chances of getting your money back are zero, but when you pay for a service on the high street which fails to deliver, they have the common decency to refund you in full.

UK pharmacists are paying for the regulator to do it's job but are getting short changed. They only go after individual pharmacists for making errors either inside or outside the workplace, and are 100% failing to tackle the root cause of all of the industry's problems. Why? Because they might have to do some real work instead of sitting behind a desk procrastinating about a decision for 6 months whilst a pharmacist's life hangs by a thread.

Ilove Pharmacy, Non Pharmacist Branch Manager

Everybody knows the real reason the GPhC do not tackle the multiples. The problem is that when it's posted on here it is swiftly removed by Waldron and co.

Job of the week

Pharmacist (qualified Independent Prescriber)
London (Central), London (Greater)
Annual salary to start at £52,000 based on a 40 hour week.